Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta

Gene Therapy

Volumn 7, Issue 8, 2000, Pages 714-722

  Annenkov, A ^a   Chernajovsky, Y ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Autoimmune arthritis; Retroviral vector; Single chain Fv domain; T lymphocytes; TCR

Indexed keywords

CELL SURFACE RECEPTOR; CHIMERIC PROTEIN; COLLAGEN TYPE 2; CONCANAVALIN A; MONOCLONAL ANTIBODY; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; COVALENT BOND; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HYBRIDOMA; IMMUNE RESPONSE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0034114370     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301149     Document Type: Article

References (40)

1. Feldmann M, Elliott MJ, Woody JN, Maini RN. Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis. Adv Immunol 1997; 64: 283-350.
2. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992; 89: 9784-9788.
3. Williams RO, Ghrayeb J, Feldmann M, Maini RN. Successful therapy of collagen-induced arthritis with TNF receptor-IgG fusion protein and combination with anti-CD4. Immunology 1995; 84: 433-439.
4. Chernajovsky Y et al. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Therapy 1995; 2: 731-735.
5. Makarov SS et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Prof Natl Acad Sci USA 1996; 93: 402-406.
6. Kuruvilla AP et al. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991; 88: 2918-2921.
7. Bessis N et al. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 1996; 26: 2399-2403.
8. Keystone E, Wherry J, Grint P. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis. Rheum Dis Clin North Am 1998; 24: 629-639.
9. Rabinovich GA et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999; 190: 385-398.
10. Robbins PD, Evans CH, Chernajovsky Y. Gene therapy for rheumatoid arthritis. Springer Semin Immunopathol 1998; 20: 197-209.
11. Seabrook T et al. The traffic of resting lymphocytes through delayed hypersensitivity and chronic inflammatory lesions: a dynamic equilibrium. Semin Immunol 1999; 11: 115-123.
12. Chernajovsky Y et al. Gene therapy for rheumatoid arthritis. Theoretical considerations. Drugs Aging 1998; 12: 29-41.
13. Mageed RA et al. Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor. Gene Therapy 1998; 5: 1584-1592.
14. Moritani M et al. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. J Clin Invest 1996; 98: 1851-1859.
15. Kramer R et al. Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nature Med 1995; 1: 1162-1166.
16. Mathisen PM et al. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 1997; 186: 159-164.
17. Shaw MK et al. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997; 185: 1711-1714.
18. Akhtar I et al. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J Exp Med 1995; 182: 87-97.
19. Chen Y et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237-1240.
20. Gua DJ, Hinton DR, Stohlman SA. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J Immunol 1995; 155: 4052-4059.
21. Kuchroo VK et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707-718.
22. Tan KN et al. Biological characteristics of an immunoregulatory activity secreted by an autoreactive CD4+ T cell clone that suppresses autoimmune diabetes in non-obese diabetic mice. Int Immunol 1996; 8: 689-699.
23. Holmdahl R et al. Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanism. Clin Exp Rheum 1989; 7 (Suppl. 3): 51-55.
24. Brocker T, Peter A, Traunecker A, Karjalainen K. New simplified molecular design for functional T cell receptor. Eur J Immunol 1993; 23: 1435-1439.
25. Holmdahl R et al. Characterisation of the antibody response in mice with type II collagen-induced arthritis, using monoclonal ant-type II collagen antibodies. Arth Rheum 1986; 29: 400-410.
26. Reth M. Antigen receptor tail clue. Nature 1989; 338: 383-384.
27. Samelson LE, Klausner RD. Tyrosine kinases and tyrosine-based activation motifs. J Biol Chem 1992; 267: 24913-24916.
28. Romeo C, Amiot M, Seed B. Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor ζ chain. Cell 1992; 68: 889-897.
29. Annenkov AE et al. Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit. J Immunol 1998; 161: 6604-6613.
30. Leo O et al. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 1987; 84: 1374-1378.
31. Michaelsson E et al. Macrophages, but not dendritic cells, present collagen to T cells. Eur J Immunol 1995; 25: 2234-2241.
32. Bonifacino JS et al. Subunit interactions within the T-cell antigen receptor: clues from the study of partial complexes. Proc Natl Acad Sci USA 1988; 85: 6929-6933.
33. Blumberg RS et al. Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex. Proc Natl Acad Sci USA 1990; 87: 7220-7224.
34. Davis MM et al. Ligand recognition by alpha beta T cell receptors. Ann Rev Immunol 1998; 16: 523-544.
35. Mallender WD, Carrero J, Voss EJ. Comparative properties of the single chain antibody and Fv derivatives of mAb 4-4-20. Relationship between interdomain interactions and the high affinity for fluorescein ligand. J Biol Chem 1996; 271: 5338-5346.
36. Kaufman Y, Berke G, Eshhar Z. Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vivo. Proc Natl Acad Sci USA 1981; 78: 2502-2506.
37. Brunsberg U et al. Expression of transgenic class II Ab gene conferes susceptibility to collagen-induced arthritis. Eur J Immunol 1994; 24: 1698-1702.
38. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
39. Brocker T, Karjalainen K. Signals through T cell receptor-zeta chain alone are insufficient to prime resting T lymphocytes. J Exp Med 1995; 181: 1653-1659.
40. Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.